United States

Bioasis establishes U.S. presence with office in Connecticut

Wednesday, October 11, 2017

Bioasis Technologies, a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier (BBB) and into the central nervous system for the treatment of neurological diseases and disorders, announced the establishment of its U.S. office in Guilford, Conn. Additionally, the company has launched its new corporate website, bioasis.us.

[Read More]

Children’s Hospital Los Angeles to study “Bubble Boy” syndrome

Tuesday, October 10, 2017

Michael Pulsipher, M.D., of the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, M.D., of Boston Children’s Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID), which prevents the immune system from functioning normally. In a multi-site study, investigators plan to determine the lowest dose of chemotherapy needed for babies with SCID undergoing bone marrow transplant—the standard treatment for SCID. The goal is to restore the immune system safely and effectively with less toxicity than the higher dose regimens currently in use.

[Read More]

NIH Director’s high-risk research awards announced for 2017

Tuesday, October 10, 2017

The NIH’s High-Risk, High-Reward Research program, part of the NIH Common Fund, funded 86 awards to exceptionally creative scientists proposing to use highly innovative approaches to tackle major challenges in biomedical research. The program supports high-risk ideas with high-impact potential, such as recording the history of an individual cell in its DNA for future playback; understanding how bacteria in the microbiome can share anti-drug-resistance genes among themselves; resetting the immune system to allow universal organ transplants; and reimagining clinical trials to make them more personalized and more effective.

[Read More]

NIH to fund seven research centers in minority institutions

Tuesday, October 10, 2017

The National Institute on Minority Health and Health Disparities (NIMHD), part of the NIH, will fund seven new awards to support the Research Centers in Minority Institutions (RCMI) Specialized Centers program. RCMI is designed to support institutional research capacity and foster the career development of new and early career investigators conducting minority health and health disparities research. The centers will share approximately $122 million over five years, pending available funds.

[Read More]

NIH to fund Centers of Excellence on Minority Health and Health Disparities

Tuesday, October 10, 2017

Twelve specialized research centers designed to conduct multidisciplinary research, research training and community engagement activities focused on improving minority health and reducing health disparities will launch. The centers, to be funded by the National Institute on Minority Health and Health Disparities (NIMHD), part of the NIH, will share approximately $82 million over five years, pending the availability of funds.

[Read More]

Bioclinica moves to New Princeton, New Jersey Office

Friday, October 6, 2017

Bioclinica, a provider of scientific-enabled Medical Imaging and eHealth solutions in clinical trials, hosted New Jersey Lt. Governor Kim Guadagno, clients and partners in an open house to celebrate the official opening of its new and larger Princeton, New Jersey facility. Following an official ribbon-cutting, guests toured the space, getting an insider’s view into the company’s work, which has supported the global regulatory approvals of more than 150 new medical treatments in Oncology, Neurosciences, Musculoskeletal and other therapeutic areas.

[Read More]

IBM Research, UCSD collaborate on artificial intelligence for healthy living

Friday, September 29, 2017

IBM and the University of California San Diego have announced a multi-year project to enhance quality of life and independence for aging populations through the new Artificial Intelligence for Healthy Living Center (AIHL), located on the campus of UC San Diego. The groundbreaking center will bring together the technology, artificial intelligence and life sciences knowledge of IBM and UC San Diego to promote critical research and applications in two thematic areas: Healthy Aging and the Human Microbiome.

[Read More]